EnVVeno Medical Corp, a key player in the Medical Devices industry, has been outperforming in the market despite a general downturn. The company boasts a robust current ratio of
20.79X, indicating strong
financial health and an ability to meet short-term obligations. Additionally, the company's total liabilities are relatively low at
$2.9M, further demonstrating its solid financial standing. However, investors should note that the company reported a significant loss of
$24.7M in net income from continuing operations, which could be a cause for concern. Despite this, the company's shares are owned by insiders and institutions at 0.54% and 29.02% respectively, indicating a level of confidence in the company's
future prospects.
Further analysis
We offer trading advice that aligns with the prevailing
expert consensus on EnVVeno Medical Corp. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's growth potential, taking into account all available technical and fundamental data. The company's dividend policy can offer insights into the current value of the stock. However, EnVVeno Medical is not anticipated to issue dividends this year as it aims to preserve or reinvest any distributable funds for stakeholders. Investing in non-dividend-paying stocks can still present opportunities for capital appreciation. Investors in such stocks depend on the stock's price appreciation over time to generate returns. When the company performs well and its stock price increases, investors can sell their shares at a higher price, thereby realizing a profit.
Typically, a company's
financial statements are the reports that show the
financial position of the company. There are three main documents that fall into the category of financial statements. These documents include EnVVeno Medical income statement, its balance sheet, and the statement of cash flows. Potential EnVVeno Medical investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although EnVVeno Medical investors may use each financial statement separately, they are all related. The changes in EnVVeno Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on EnVVeno Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our
technical analysis and
fundamental analysis pages.
The goal of EnVVeno Medical
fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of EnVVeno Medical performance into the future periods or doing a reasonable stock valuation. The intrinsic value of EnVVeno Medical shares is the value that is considered the true value of the share. If
the intrinsic value of EnVVeno is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares EnVVeno Medical. Please read more on our
fundamental analysis page.
How effective is EnVVeno Medical in utilizing its assets?
enVVeno Medical Corp reports assets on its Balance Sheet. It represents the amount of EnVVeno resources that either has an existing economic value or will provide some form of benefits in the future. By effectively utilizing its assets, EnVVeno Medical aims to generate revenue, control costs, drive operational efficiency, and enhance profitability. Optimizing asset utilization helps maximize shareholder value and maintain a competitive position in the Health Care Equipment & Supplies space. To get a better handle on how balance sheet or income statements item affect EnVVeno volatility, please check the breakdown of all its
fundamentals.
Are EnVVeno Medical Earnings Expected to grow?
The
future earnings power of EnVVeno Medical involves the interaction of many company-specific, industry, and economic forces. Earnings estimates embody investors' opinions of EnVVeno Medical factors such as sales growth, product demand, competitive industry environment, profit margins, and cost controls. EnVVeno Medical
stock prices adjust as these expectations change or are proven wrong. The main thing to remember is that equities with high expected earnings growth tend to underperform the market because it is usually difficult to meet the market's high expectations. Companies with low earnings expectations tend to do better than expected. Please use our latest analysis of EnVVeno
expected earnings.
EnVVeno Medical Gross Profit
EnVVeno Medical Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing EnVVeno Medical previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show EnVVeno Medical Gross Profit growth over the last 10 years. Please check EnVVeno Medical's
gross profit and other
fundamental indicators for more details.
Breaking it down a bit more
The recent EnVVeno Medical Corp price decline may encourage insiders to take a closer look at the firm as it is trading at a share price of
3.94 on
44,514 in trading volume. The company executives were unable to exploit market volatilities in
June. However, diversifying your overall positions with EnVVeno Medical Corp can protect your principal portfolio during market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.26. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the EnVVeno Medical partners.
| 2018 | 2019 | 2022 | 2023 (projected) |
Revenues USD | 186.55 K | 31.24 K | 28.12 K | 28.86 K | Revenues | 186.55 K | 31.24 K | 28.12 K | 28.86 K |
Asset Utilization
One of the ways to look at asset utilization of EnVVeno is to check how much profit was generated for every dollar of assets it reports. EnVVeno Medical Corp shows a negative utilization of assets of -0.36 percent, losing $0.003632 for each dollar of assets held by the firm. Ineffective asset utilization denotes the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of EnVVeno Medical Corp shows how unsuccessful it operates for each dollar spent on its assets.
| Current Assets | 42.55 Million | 93.61 |
| Assets Non Current | 2.17 Million | 4.76 |
| Goodwill | 737,954 | 1.62 |
EnVVeno Medical Corp, a prominent player in the Health Care Equipment & Supplies sector, has been making waves in the NASDAQ exchange, outperforming even amidst a market downturn. The company's stock has seen a commendable 52-week high of $7.93, showcasing its potential for robust growth. Despite reporting net income losses of $24.7M, the company's strong current ratio of 20.79X indicates its ability to meet short-term obligations, a key factor in maintaining investor confidence. Interestingly, EnVVeno Medical Corp's shares float stands at 8.6M, with 29.02% of the shares owned by institutions, signifying a substantial institutional interest. The company has a beta of 1.28, suggesting a higher volatility compared to the overall market. However, the company's book value of $3.603 per share and net tangible assets of
$38.7M underpin its intrinsic value. The company has been diligently investing in research and development, spending $9.9M, which is a promising sign for future growth. Despite a negative free cash flow of $15.7M and total cash from operating activities standing at
-$15.6M, the company holds a cash reserve of $4.6M. With 30 full-time employees, EnVVeno Medical Corp is navigating the market downturn with strategic financial management and a focus on innovation.
Our perspective of the recent EnVVeno Medical roll up
In our recent analysis of EnVVeno Medical Corp, we've observed a significant shift in the stock's statistical behavior. As of today, the kurtosis has decreased to 0.89, indicating a less extreme distribution of returns. This suggests a potential reduction in the stock's volatility, potentially creating a less risky environment for investors. As a result, EnVVeno's stock may become a more attractive option for those seeking stability in the face of market fluctuations. This development is a crucial aspect of EnVVeno Medical Corp's recent progress, and we believe it's worth considering in your investment decisions. EnVVeno Medical Corp displays very low volatility, with a skewness of 0.46 and a kurtosis of 0.89. However, we recommend that investors further investigate EnVVeno Medical Corp's technical indicators to ensure all market information is available and reliable. Understanding different
market volatility trends often assists investors in timing the market. Proper use of volatility indicators allows traders to measure EnVVeno Medical's stock risk against market volatility during both bullish and bearish trends.
The heightened level of volatility that accompanies bear markets can directly impact
EnVVeno Medical's stock price, adding stress for investors as they watch the value of their shares decline. This often compels investors to rebalance their portfolios by purchasing different stocks as prices drop. In conclusion, despite the modest market decline, EnVVeno Medical Corp has shown a strong advancement today. With an analyst target price estimated value of
23, and the highest and lowest estimated target price also standing at
23, the company presents a potential upside price of 9.31. The valuation real value is 8.53, which, when compared to the valuation market value of 3.94, indicates a significant undervaluation. The analyst overall consensus is a 'Strong Buy', further solidifying the investment potential. However, investors should be aware of the possible downside price of 0.0394. Given these factors, EnVVeno Medical Corp presents a promising investment opportunity. .
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of enVVeno Medical Corp. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com